OOIR: Observatory of International Research

Papers

(The H4-Index of Medicinal Research Reviews is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
	203
	193
	174
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy	169
Key characters of glycodrugs	144
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery	128
New drug approvals for 2022: Synthesis and clinical applications	119
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders	116
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment	107
The role and prospect of lysine‐specific demethylases in cancer chemoresistance	89
Galectin‐8 inhibition and functions in immune response and tumor biology	88
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers	88
Front Cover Image, Volume 45, Issue 1	81
	77
Current and emerging approaches to noncompetitive AR inhibition	76
A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses	75
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents	73
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel	71
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders	67
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer	66
Enhancing healthy aging with small molecules: A mitochondrial perspective	65
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing	65
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review	64
Current nanocomposite advances for biomedical and environmental application diversity	58
α‐Synuclein in Parkinson's Disease: From Bench to Bedside	52

Mitochondrial quality control proteases and their modulation for cancer therapy	47
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases	46
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators	42
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases	42
Emerging roles of nerve‐bone axis in modulating skeletal system	40
Issue Information	39
Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer Therapy	37
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis	36
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds	35
Human Cyclophilins—An Emerging Class of Drug Targets	35